13-72761421-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_014953.5(DIS3):c.2612G>A(p.Gly871Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000987 in 1,610,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000099 ( 0 hom. )
Consequence
DIS3
NM_014953.5 missense
NM_014953.5 missense
Scores
9
6
4
Clinical Significance
Conservation
PhyloP100: 4.82
Genes affected
DIS3 (HGNC:20604): (DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease) Enables 3'-5'-exoribonuclease activity; endonuclease activity; and guanyl-nucleotide exchange factor activity. Involved in CUT catabolic process and rRNA catabolic process. Located in cytosol and nucleoplasm. Part of nuclear exosome (RNase complex). [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.835
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIS3 | NM_014953.5 | c.2612G>A | p.Gly871Glu | missense_variant | 19/21 | ENST00000377767.9 | NP_055768.3 | |
DIS3 | NM_001128226.3 | c.2522G>A | p.Gly841Glu | missense_variant | 19/21 | NP_001121698.1 | ||
DIS3 | NM_001322348.2 | c.2243G>A | p.Gly748Glu | missense_variant | 18/20 | NP_001309277.1 | ||
DIS3 | NM_001322349.2 | c.2126G>A | p.Gly709Glu | missense_variant | 20/22 | NP_001309278.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIS3 | ENST00000377767.9 | c.2612G>A | p.Gly871Glu | missense_variant | 19/21 | 1 | NM_014953.5 | ENSP00000366997.4 |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 152026Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
15
AN:
152026
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000602 AC: 15AN: 248966Hom.: 0 AF XY: 0.0000817 AC XY: 11AN XY: 134586
GnomAD3 exomes
AF:
AC:
15
AN:
248966
Hom.:
AF XY:
AC XY:
11
AN XY:
134586
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000987 AC: 144AN: 1458940Hom.: 0 Cov.: 31 AF XY: 0.0000965 AC XY: 70AN XY: 725702
GnomAD4 exome
AF:
AC:
144
AN:
1458940
Hom.:
Cov.:
31
AF XY:
AC XY:
70
AN XY:
725702
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000987 AC: 15AN: 152026Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74254
GnomAD4 genome
AF:
AC:
15
AN:
152026
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74254
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.2612G>A (p.G871E) alteration is located in exon 19 (coding exon 19) of the DIS3 gene. This alteration results from a G to A substitution at nucleotide position 2612, causing the glycine (G) at amino acid position 871 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H;.;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at